Pharmaceutical composition preventing or treating an influenza viral infectious disease
AssigneePostech Academy-Industry Foundation
InventorsJoo-Yeon YOO, Na Rae AHN
Life of this patent
Estimating the term…
Abstract
The present invention provides a vaccine composition and pharmaceutical composition for preventing or treating a viral infectious disease comprising one or more selected from the group consisting of SPOCK2 protein and a gene encoding the SPOCK2 protein as an active ingredient, a method of preparing the same, and prevention and treatment method.
Claims18
A DNA vaccine composition for preventing or treating a viral infectious disease, comprising a gene encoding SPOCK2 protein.
A DNA vaccine composition for preventing or treating an influenza viral infectious disease, comprising one or more selected from the group consisting of SPOCK2 protein, a polynucleotide encoding the SPOCK2 protein, a vector comprising the polynucleotide and a cell comprising the vector, as an active ingredient.
A method for preparing a DNA vaccine of influenza virus, comprising
- a step of modifying a codon of a gene encoding SPOCK2 protein to be overexpressed in a cell;
- and
- a step of introducing the modified gene into a vector.
Dependencies are inferred from the claim text.